Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
ORTINGLOBE
₹15.26
₹15.10
₹15.89
₹10.66
₹21.30
Markets Today
Historical Performance
As of 25-08-2026 00:51, Ortin Global Ltd. share price today is ₹0, with a change of ₹-15.89 (-100.00%) from the previous close of ₹15.89. The stock opened at ₹15.1 and traded between ₹15.1 and ₹15.89, with a total traded volume of 3259 shares. The company has a market capitalization of ₹12.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹21.3 and ₹10.66, respectively.
Ortin Global Ltd. valuation metrics include a P/E ratio of -14.3, and book value of ₹14.40. Profitability indicators show ROE of -59.84%. Ortin Global Ltd. has reported revenue of ₹0.07 Cr and net profit of ₹-0.9 Cr.
Ortin Global Ltd. technical indicators include Day RSI at 54.24, Day MFI at 65.66, Day ADX at 16.86. Additional indicators include Commodity Channel Index (CCI) at 87.1 and Williams %R at -29.05. Momentum indicators show Day MACD at 0.04, Day MACD Signal Line at -0.09, DayATR at 1. Rate of Change indicators for Ortin Global Ltd. include ROC125 at -7.62 and ROC21 at 6.57.
Exponential moving averages include EMA5 at ₹15.8, EMA10 at ₹15.7, EMA12 at ₹15.6, EMA20 at ₹15.6, EMA26 at ₹15.6, EMA50 at ₹15.7, EMA100 at ₹15.6, EMA200 at ₹15.1. Simple moving averages include SMA5 at ₹15.8, SMA10 at ₹15.6, SMA20 at ₹15.3, SMA30 at ₹15.3, SMA50 at ₹16, SMA100 at ₹15.7, SMA150 at ₹15.5, SMA200 at ₹14.8.
Support levels for Ortin Global are placed at First Support ₹15.55, Second Support ₹15.21, Third Support ₹15.01. Resistance levels are seen at First Resistance ₹16.09, Second Resistance ₹16.29, Third Resistance ₹16.63. Ortin Global Ltd. shareholding pattern shows promoter holding at 1.23%, FII holding at 1.8%, DII holding at 0%, public holding at 96.96%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 0.01 | 0.03 | 0.01 | 0.01 | 0.04 |
| Operating Expense | 0.35 | 0.32 | 0.06 | 0.52 | 0.24 |
| Operating Profit | -0.34 | -0.28 | -0.05 | -0.50 | -0.20 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0.01 |
| Net Profit | -0.34 | -0.01 | -0.05 | -0.50 | -0.18 |
₹15.26
↗ Bullish Moving Average
15
↘ Bearish Moving Average
1
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| FII | 6.5 | 6.5 | 1.7 | 1.7 | 1.7 | 1.8 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 92.2 | 92.2 | 97.1 | 97.1 | 97.1 | 97 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.41 K | 3.41 K | 100.00% |
| Week | 7.19 K | 9.18 K | 78.32% |
| 1 Month | 15.32 K | 17.13 K | 89.44% |
| 6 Month | 17.75 K | 18.96 K | 93.60% |
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Sep, 2013 | 0.25 | FINAL | Equity Share | |
| 24 Sep, 2012 | 0.5 | FINAL | Equity Share | |
| 13 Oct, 2011 | 0.5 | FINAL | 15 Oct, 2011 | Equity Share |
| 23 Sep, 2010 | 0.8 | FINAL | Equity Share | |
| 23 Sep, 2009 | 0.8 | FINAL | Equity Share | |
| 24 Sep, 2008 | 0.8 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹526.25 | ₹6.55 | ₹205.20 | ₹15.46 | ₹518.70 | ₹100.52 |
| % Change | -2.70% | 4.97% | 4.81% | 8.26% | -3.29% | 4.99% |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹291.17 | ₹226.23 | ₹511.48 | ₹305.93 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹14.68 | ₹31.63 | ₹53.97 | ₹16.01 |
| PE TTM | 115.10 | -0.30 | 51.80 | 2.40 | 28.70 | 32.50 |
| 1 Year Return | 37.97 | 524 | 55.39 | 56.92 | -23.59 | 8.81 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 30.45
+1.33%
Windlas Biotech Ltd.
₹ 988.00
-0.56%
Vineet Laboratories Ltd.
₹ 37.00
-2.14%
Solara Active Pharma Sciences Ltd.
₹ 628.00
+1.80%
Zim Laboratories Ltd.
₹ 124.16
-0.70%
Medico Remedies Ltd.
₹ 42.09
-1.31%
Dishman Carbogen Amcis Ltd.
₹ 173.00
-0.31%
Lasa Supergenerics Ltd.
₹ 7.33
+1.81%
Haleos Labs Ltd.
₹ 1500.00
+2.39%
Advanced Enzyme Technologies Ltd.
₹ 302.20
+0.73%
Bajaj Healthcare Ltd.
₹ 322.00
+0.00%
Brooks Laboratories Ltd.
₹ 61.70
+2.83%
RPG Life Sciences Ltd.
₹ 2638.00
+0.05%
Bafna Pharmaceuticals Ltd.
₹ 254.55
+4.99%
Alpa Laboratories Ltd.
₹ 61.20
-2.47%
SMS Pharmaceuticals Ltd.
₹ 354.00
-0.73%
Nectar Lifesciences Ltd.
₹ 10.80
+3.15%
Mangalam Drugs and Organics Ltd.
₹ 30.44
+9.97%
Indoco Remedies Ltd.
₹ 220.00
-2.78%
Ind-Swift Laboratories Ltd.
₹ 325.35
-1.29%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
-0.33%
Panacea Biotec Ltd.
₹ 406.50
-1.12%
Medicamen Biotech Ltd.
₹ 234.00
-4.31%
Themis Medicare Ltd.
₹ 120.50
+13.53%
By signing up I certify terms, conditions & privacy policy